A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types
Clinical trial NCT04311710 · TERMINATED
Trial details
- NCT number
- NCT04311710
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-25
- Primary completion
- 2021-01-14
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.